Lexeo Therapeutics, Inc. ($LXEO)
Filing Information
| Accession Number | 0002109299-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 28, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
57,464
Total Value
$9,713.41
P&L
-12.3% ($1,191.45)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 14, 2026 | Grant/Award | 2,714 | $3.58 | $9,713.41 | 84,908 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 24, 2026 | Grant/Award | 54,750 | $0.00 | $0.00 | 54,750 | Direct | โ | View Details |